Freeman v. Hoffman-La Roche, Inc.
300 Neb. 47
Neb.2018Background
- Freeman sued Roche alleging Accutane (isotretinoin) caused her inflammatory bowel disease (diagnosed as Crohn’s disease); she relied on Dr. David B. Sachar for general and specific causation opinions.
- Roche moved in limine under Daubert/Schafersman to exclude Sachar’s causation testimony, challenging the reliability and application of his methodology (not his qualifications).
- At a Daubert/Schafersman hearing, the district court found Sachar used a weight-of-the-evidence approach but applied it inconsistently, cherry-picked studies, and treated conflicting epidemiological evidence unfairly.
- The court concluded Sachar’s methodology was conclusion-driven and unreliable, excluded his testimony in a detailed 42-page order, and sustained Roche’s motion in limine.
- Roche then moved for summary judgment; the district court granted it because, without admissible expert proof on causation, Freeman could not create a genuine issue of material fact.
- Freeman appealed, arguing the court overstepped gatekeeping and improperly excluded her expert and thus erred in granting summary judgment.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the trial court required too much and improperly excluded Sachar’s expert testimony under Daubert/Schafersman | Freeman: court invaded the jury’s role and should have admitted Sachar’s opinions; methodology was acceptable | Roche: Sachar’s causation opinions were based on unreliable, conclusion-driven application of weight-of-evidence and cherry-picking | Court: No abuse of discretion; methodology was unreliably applied and testimony properly excluded |
| Whether Sachar employed an accepted and reliably applied methodology for general and specific causation | Freeman: weight-of-the-evidence is an accepted method and Sachar applied it adequately | Roche: Sachar selectively dismissed adverse epidemiology and failed to apply consistent standards across evidence types | Court: Weight-of-the-evidence is acceptable, but Sachar’s inconsistent standards and cherry-picking failed the required intellectual rigor |
| Whether summary judgment was proper after exclusion of expert testimony on causation | Freeman: If Sachar’s testimony were admitted, a factual dispute on causation would exist | Roche: Without admissible expert causation evidence, Freeman cannot prove an essential element and is entitled to judgment | Court: Proper; exclusion left Freeman with no admissible evidence of causation, so summary judgment for Roche affirmed |
Key Cases Cited
- Daubert v. Merrell Dow Pharm., 509 U.S. 579 (trial courts must assess reliability and relevance of expert scientific testimony)
- Schafersman v. Agland Coop, 262 Neb. 215 (Nebraska’s adoption of Daubert gatekeeping standards)
- King v. Burlington Northern Santa Fe Ry. Co., 277 Neb. 203 (weight-of-the-evidence methodology and standards for expert causation testimony)
- State v. Braesch, 292 Neb. 930 (factors for evaluating expert reliability under Daubert/Schafersman)
